MicroSort is a laboratory technology that helps medical teams analyze and sort reproductive cells with greater precision.
Its purpose is to reduce the risk of certain hereditary conditions being passed on to the next generation, supporting safer fertility treatments for families.
Yes. MicroSort uses non-invasive, light-based cell analysis, which does not change or damage the genetic material of the cells.
The process has been developed through years of research and applied in clinical settings under strict quality and safety standards.
MicroSort is designed for families who may have a history of inherited conditions and wish to reduce potential risks during assisted reproduction.
It can also be valuable for fertility specialists seeking to improve embryo quality and treatment outcomes.
MicroSort technology is currently operated in Mexico, Malaysia, North Cyprus, Japan, Thailand, Cambodia and Nigeria, with experienced local medical teams providing professional support.
We collaborate with fertility centers and hospitals worldwide to make MicroSort available through device deployment and cartridge supply partnerships.
Clinics interested in adopting the technology can [contact our team] for more details on collaboration opportunities.
